2.125mg tirzepatide CASA PHARMACY - LOW DOSE - 2.5mg/0.5ml can help you on a transformative journey towards a healthier lifestyle Tirzepatide Flex-Dose 1 mL Injectable

While the study cannot establish causation, investigators say the results provide a strong rationale for prospective clinical trials evaluating whether GLP-1 drugs could become part of future breast cancer prevention strategies

Pituitary (2020) 23:23245

Tirzepatide is a weight loss medication administered via injection

Weight loss typically accelerates as the dose is gradually increased over 16 weeks to the maintenance dose of 2.4 mg weekly for weight management

Safety and Side Effects GLP-1 receptor agonists are generally safe, with predictable side effects: Gastrointestinal symptoms such as nausea, vomiting, and diarrhea are common but usually improve with gradual dose titration